Regulating flavours and flavour delivery technologies: an analysis of menthol cigarettes and RYO tobacco in Aotearoa New Zealand
Conclusions
Capsule technologies using menthol flavours work synergistically to enhance the appeal of smoking and appear likely to encourage experimentation among non-smoking young people. Comprehensive policy that regulates menthol flavours and innovations used to deliver flavour sensations will support tobacco endgame goals in NZ and could inform policy in other countries. (Source: Tobacco Control)
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Gendall, P., Hoek, J. Tags: Brief report Source Type: research
Analysis of FDAs Vuse market authorisation: limitations and opportunities
This special communication provides a physicians’ critique of the US Food and Drug Administration (FDA)’s decision to authorise the Vuse Solo (Vuse) Premarket Tobacco Application (PMTA). The PMTA authorisation represents the first time that FDA has authorised an Electronic Nicotine Delivery System (ENDS) for marketing in the USA. Using the FDA Decision Summary, the special communication identifies significant unanswered public health and scientific questions that prevent the authors from reaching FDA’s conclusion that Vuse meets the Appropriate for the Protection of the Public Health (APPH) standard. The ...
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Meshnick, A. B., Faricy, L. E., Lushniak, B. D. Tags: Special communication Source Type: research
Vuse Solo e-cigarettes do not provide net benefits to public health: a scientific analysis of FDAs marketing authorisation
In October 2021, the US Food and Drug Administration (FDA) authorised marketing of RJ Reynolds Vapor Company’s (RJR) Vuse Solo e-cigarette through FDA’s Premarket Tobacco Product Application (PMTA) pathway. FDA concluded that RJR demonstrated Vuse products met the statutory standard of providing a net benefit to public health. A review of FDA’s scientific justification reveals deficiencies: (1) not adequately considering Vuse’s popularity with youth and evidence that e-cigarettes expanded the nicotine market and stimulate cigarette smoking; (2) trading youth addiction for unproven adult benefit with...
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Glantz, S., Lempert, L. K. Tags: Special communication Source Type: research
How might FDA fix this e-cigarette PMTA mess? Commentary on Glantz and Lempert and Meshnick et al
In their articles critiquing the US Food and Drugs Administration’s (FDA) first marketing order to allow the legal marketing of any e-cigarette, for Vuse Solo tobacco-flavoured e-cigarettes, Glantz and Lempert and Meshnick et al discuss a range of serious procedural, technical and substantive problems with FDA’s publicly released explanation of how its evaluation of the Vuse application supports that order as appropriate for the protection of the public health.1 2 Those problems are too numerous to list here, but Glantz and Lempert and Meshnick et al reasonably conclude that FDA should withdraw its order allowi...
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Lindblom, E. N. Tags: Open access Commentary Source Type: research
Addiction potential of combustible menthol cigarette alternatives: a randomised cross-over trial
Conclusions and relevance
mRYO cigarettes were the most highly rated cigarette alternative among study products, suggesting their potential appeal as a menthol cigarette substitute and needed inclusion of menthol pipe tobacco and cigarette tubes in FDA’s proposed ban. (Source: Tobacco Control)
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Wagener, T. L., Mehta, T., Hinton, A., Schulz, J. A., Erath, T. G., Tidey, J., Brinkman, M. C., Wilson, C., Villanti, A. C. Tags: Open access Original research Source Type: research
As countries improve their cigarette tax policy, cigarette consumption declines
Conclusions
Our results provide evidence on the association between higher cigarette tax scores and lower cigarette consumption. To reduce tobacco consumption, governments must strive to implement all four components in the Cigarette Tax Scorecard at the highest level. (Source: Tobacco Control)
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Ngo, A., Drope, J., Guerrero-Lopez, C. M., Siu, E., Chaloupka, F. J. Tags: Open access Original research Source Type: research
Impact of waterpipe tobacco taxation on consumption, government revenue and premature deaths averted in Jordan, Lebanon and Palestine: a simulation study
Discussion
Increases in waterpipe tobacco-specific excise taxes substantially reduce smoking and increase government revenue and averted premature deaths in Jordan, Lebanon and Palestine. This has positive implications for both public health and financing and should be considered a policy priority. (Source: Tobacco Control)
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Jawad, M., Awawda, S., Abla, R., Chalak, A., Khader, Y. S., Nakkash, R. T., Mostafa, A., Salloum, R. G., Abu-Rmeileh, N. M. E. Tags: Open access Original research Source Type: research
Cigarette prices and smoking among adults in eight sub-Saharan African countries: evidence from the Global Adult Tobacco Survey
Conclusions
Higher cigarette prices significantly decrease the likelihood of smoking and decrease the intensity of cigarette consumption among African adults. Increases in the excise tax that increase the retail price of cigarettes will play an important role in reducing adult tobacco use on the continent. Governments are encouraged to increase excise taxes to improve public health. (Source: Tobacco Control)
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Filby, S. Tags: Open access Original research Source Type: research
Impact of FDA endorsement and modified risk versus exposure messaging in IQOS ads: a randomised factorial experiment among US and Israeli adults
Conclusions
Regulators must monitor direct and indirect advertising content of modified risk tobacco product-authorised products and prevent potentially harmful misinterpretations. (Source: Tobacco Control)
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Berg, C. J., Duan, Z., Wang, Y., Thrasher, J. F., Bar-Zeev, Y., Abroms, L. C., Romm, K. F., Khayat, A., Levine, H. Tags: Original research Source Type: research
Trajectories of ENDS and cigarette use among dual users: analysis of waves 1 to 5 of the PATH Study
Conclusions
Most dual users maintained long-term cigarette smoking or dual use, highlighting the need to address cessation of both products. Continued monitoring of trajectories and their predictors is needed, given ongoing changes to the ENDS marketplace. (Source: Tobacco Control)
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Krishnan, N., Berg, C. J., Elmi, A. F., Klemperer, E. M., Sherman, S. E., Abroms, L. C. Tags: Press releases Original research Source Type: research
PMIs IQOS and cigarette ads in Israeli media: a content analysis across regulatory periods and target population subgroups
Conclusions
IQOS advertisement content shifted as more restrictions went into effect, with several elements used to circumvent legislation. Findings from this study point to the necessity of a complete advertisement ban and ongoing marketing surveillance. (Source: Tobacco Control)
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Khayat, A., Berg, C. J., Levine, H., Rodnay, M., Abroms, L., Romm, K. F., Duan, Z., Bar-Zeev, Y. Tags: Original research Source Type: research
The impact of cigarette prices on smoking onset and cessation: evidence from Vietnam
Conclusion
Vietnam should continue to increase excise taxes on tobacco products to reduce smoking onset. Since smokers are resilient to excise tax increases, other tobacco control policies, such as smoke-free areas and tobacco advertisement bans, should be better enforced to encourage people to quit. Other policies not yet implemented, such as plain packaging of tobacco products, may also encourage smokers to quit. (Source: Tobacco Control)
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Nguyen, C. V., Vellios, N., Nguyen, N. H., Le, T. T. Tags: Original research Source Type: research
Reducing attractiveness of e-liquids: proposal for a restrictive list of tobacco-related flavourings
Conclusions
Implementing this restrictive list will likely discourage e-cigarette use among youth, but could also make e-cigarettes less attractive as smoking cessation aid. (Source: Tobacco Control)
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Pennings, J. L. A., Havermans, A., Krüsemann, E. J. Z., Zijtveld, D., Huiberts, E. H. W., Bos, P. M. J., Schenk, E., Visser, W. F., Bakker-'t Hart, I. M. E., Staal, Y. C. M., Talhout, R. Tags: Open access Original research Source Type: research
Nicotine pouches: a summary of regulatory approaches across 67 countries
Conclusion
Our work offers novel insight into nicotine pouch markets and national regulatory approaches. Policy approaches vary from not regulating nicotine pouches at all to banning both forms of nicotine pouches. Policies used by countries regulating both tobacco-derived and synthetic nicotine pouches offer a roadmap for how other jurisdictions can add effective guardrails to the use of these and other non-medicinal nicotine products. (Source: Tobacco Control)
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Duren, M., Atella, L., Welding, K., Kennedy, R. D. Tags: Editor's choice Original research Source Type: research
How do people who smoke perceive a tobacco retail outlet reduction policy in Aotearoa New Zealand? A qualitative analysis
Conclusions
Many participants hoped to become smoke-free and thought retail reduction measures would prompt quit attempts and reduce relapse. Adopting a holistic well-being perspective, such as those developed by Māori, could address concerns about unintended adverse outcomes and provide comprehensive support to people who smoke as they adjust to a fundamental change in tobacco availability. (Source: Tobacco Control)
Source: Tobacco Control - March 19, 2024 Category: Respiratory Medicine Authors: Graham-DeMello, A., Hoek, J. Tags: Open access Original research Source Type: research
